Lipids profile among ART-naïve HIV infected patients and men who have sex with men in China: a case control study

[1]  S. Oparil,et al.  2018 Practice guidelines for the management of arterial hypertension of the European Society of Hypertension , 2018, Blood pressure.

[2]  M. Bukrinsky,et al.  HIV infection induces structural and functional changes in high density lipoproteins. , 2015, Atherosclerosis.

[3]  M. Kuti,et al.  Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria—Implications for Care , 2015, Journal of the International Association of Providers of AIDS Care.

[4]  M. Myerson.  Lipid management in human immunodeficiency virus. , 2015, Cardiology clinics.

[5]  N. Husain,et al.  Managing dyslipidemia in HIV/AIDS patients: challenges and solutions , 2014, HIV/AIDS.

[6]  E. Rosenberg,et al.  High-Density Lipoprotein-Mediated Cholesterol Efflux Capacity Is Improved by Treatment With Antiretroviral Therapy in Acute Human Immunodeficiency Virus Infection , 2014, Open forum infectious diseases.

[7]  C. Onyedum,et al.  Atherogenic index of plasma in highly active antiretroviral therapy-naïve patients with human immunodeficiency virus infection in Southeast Nigeria , 2014, Indian journal of endocrinology and metabolism.

[8]  Daniel A. Botero-Rosas,et al.  Factores de riesgo cardiovascular y su relación con la composición corporal en estudiantes universitarios , 2014 .

[9]  Molla Abebe,et al.  Antiretroviral treatment associated hyperglycemia and dyslipidemia among HIV infected patients at Burayu Health Center, Addis Ababa, Ethiopia: a cross-sectional comparative study , 2014, BMC Research Notes.

[10]  H. Qian,et al.  Recreational Drug Use among Chinese Men Who Have Sex with Men: A Risky Combination with Unprotected Sex for Acquiring HIV Infection , 2014, BioMed research international.

[11]  J. Ananworanich,et al.  High Prevalence of Lipid Abnormalities among Antiretroviral-Naive HIV-Infected Asian Children with Mild-To-Moderate Immunosuppression , 2011, Antiviral therapy.

[12]  T. Asonganyi,et al.  Serum lipid profile in highly active antiretroviral therapy‐naïve HIV‐infected patients in Cameroon: a case–control study , 2010, HIV medicine.

[13]  R. Kronmal,et al.  Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study , 2009, AIDS.

[14]  Li Yang,et al.  The changing face of HIV in China , 2008, Nature.

[15]  Z. Hussain,et al.  Electronic structure of the iron-based superconductor LaOFeP , 2008, Nature.

[16]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[17]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[18]  O. Kirk,et al.  Class of antiretroviral drugs and the risk of myocardial infarction. , 2007, The New England journal of medicine.

[19]  W. El-Sadr,et al.  Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral‐naïve cohort , 2005, HIV medicine.

[20]  G. Greenwood,et al.  Alcohol use, drug use and alcohol-related problems among men who have sex with men: the Urban Men's Health Study. , 2001, Addiction.

[21]  J. Frohlich,et al.  The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). , 2001, Clinical biochemistry.

[22]  R. Hogg,et al.  Lipodystrophy-associated morphological, cholesterol and triglyceride abnormalities in a population-based HIV/AIDS treatment database , 2001, AIDS.

[23]  David A. Cooper,et al.  A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors , 1998, AIDS.

[24]  Jeani Chang,et al.  Hypocholesterolemia is associated with immune dysfunction in early human immunodeficiency virus-1 infection. , 1993, The American journal of medicine.

[25]  K. Feingold,et al.  Lipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndrome. , 1992, The Journal of clinical endocrinology and metabolism.

[26]  M. Sension,et al.  Lipid metabolism and lipodystrophy in HIV-1-infected patients: the role played by nonnucleoside reverse transcriptase inhibitors. , 2015, AIDS reviews.

[27]  D. Botero-Rosas,et al.  [University students'’ cardiovascular risk factors and their relationship with body composition]. , 2014, Revista de salud publica.

[28]  L. Kuller,et al.  HIV infection, antiretroviral therapy initiation and longitudinal changes in biomarkers of organ function. , 2014, Current HIV research.

[29]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[30]  C. Daniyam,et al.  Lipid Profile of Anti-Retroviral Treatment-Naïve HIV-Infected Patients in Jos, Nigeria , 2013, Annals of medical and health sciences research.

[31]  M. Dobiášová.  [AIP--atherogenic index of plasma as a significant predictor of cardiovascular risk: from research to practice]. , 2006, Vnitrni lekarstvi.

[32]  Cardiovascular disease risk factors: new areas for research. Report of a WHO Scientific Group. , 1994, World Health Organization technical report series.